60 Degrees Pharmaceuticals, Inc.
SXTPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001946563
No open-market purchases or sales by 60 Degrees Pharmaceuticals, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.
Other share classesSXTP
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 5
- 13F valueReported value at the end of Q2 2026
- $12.2K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding SXTPW, Q2 2026
No superinvestor reported holding SXTPW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by 60 Degrees Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 12 | 3 days | Dow Geoffrey SPresident and CEO | PPurchase | +7.35K | $1.38 | +$10.1K | +43.8%24.1K after | |
| Dec 16, 2025 (view filing) | Dec 15 | 1 day | Dow Geoffrey SPresident and CEO | PPurchase | +9.67K | $0.80 | +$7.74K | +19.4%59.6K after | |
| Dec 12, 2025 (view filing) | Dec 10-11 | 2 days | Dow Geoffrey SPresident and CEO | PPurchase | +13.0K | $0.9416 | +$12.2K | +35.0%49.9K after | 2 lots |
| Jun 5, 2025 (view filing) | Jun 3 | 2 days | Xu CherylDirector | PPurchase | +5.00K | $2.88 | +$14.4K | +46.2%15.8K after | 2 lots |
| Dec 18, 2024 (view filing) | Dec 12-16 | 6 daysLate | Xu CherylDirector | PPurchase | +13.0K | $1.65 | +$21.4K | +31.6%54.1K after | 7 lots |
| Dec 9, 2024 (view filing) | Dec 5-9 | 4 days | Dow Geoffrey SPresident and CEO | PPurchase | +74.0K | $1.21 | +$89.7K | +358.5%94.6K after | 3 lots |
| Nov 21, 2024 (view filing) | Nov 19-21 | 2 days | Dow Geoffrey SPresident and CEO | PPurchase | +7.00K | $0.9079 | +$6.36K | +51.4%20.6K after | 3 lots |
| Sep 11, 2024 (view filing) | Aug 27 | 15 daysLate | Xu CherylDirector | PPurchase | +5.00K | $1.70 | +$8.50K | +13.9%41.1K after | |
| Feb 2, 2024 (view filing)3:33 PM ET | Jan 31 | 2 days | Dow Geoffrey SPresident and CEO | PPurchase | +26.0K | $0.375 | +$9.74K | +3.8%703.6K after | |
| Feb 2, 2024 (view filing)3:33 PM ET | Jan 31 | 2 days | Dow Geoffrey SPresident and CEO | PPurchase | +26.0K | $0.01 | +$259.74 | –26.0K after | Derivative |
Top 10 13F holders, Q2 2026
The largest institutional positions in 60 Degrees Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 200,481 | $6.05K | 0.00% | 00.0% | Unchanged |
| Clear Street Group Inc. | 145,969 | $4.41K | 0.00% | 00.0% | Unchanged |
| Torno Capital, LLC | 47,169 | $1.43K | 0.00% | −47,169−50.0% | Reduced |
| Susquehanna International Group, LLP | 10,892 | $329 | 0.00% | −7,271−40.0% | Reduced |
| UBS Group AG | 647 | $20 | 0.00% | −55−7.8% | Reduced |